| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
794 |
663 |
$29K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,355 |
1,193 |
$27K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
62 |
53 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
374 |
373 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
368 |
367 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
629 |
625 |
$5K |
| 80061 |
Lipid panel |
1,372 |
1,367 |
$4K |
| 99221 |
|
120 |
95 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
249 |
231 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,121 |
1,115 |
$3K |
| 80053 |
Comprehensive metabolic panel |
860 |
816 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,506 |
1,425 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
674 |
622 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
113 |
78 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21 |
20 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
346 |
341 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
320 |
306 |
$1K |
| 82607 |
|
91 |
90 |
$1K |
| 82746 |
|
84 |
84 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
183 |
182 |
$904.53 |
| 93000 |
|
32 |
29 |
$880.71 |
| 86803 |
|
191 |
190 |
$856.41 |
| 99385 |
|
14 |
14 |
$798.70 |
| 84439 |
|
118 |
116 |
$759.51 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
85 |
84 |
$744.64 |
| 83013 |
|
13 |
12 |
$721.20 |
| 97802 |
|
35 |
28 |
$546.30 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
26 |
26 |
$480.34 |
| 87088 |
|
118 |
117 |
$463.73 |
| 81001 |
|
580 |
572 |
$440.45 |
| 87340 |
|
136 |
135 |
$438.13 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
103 |
98 |
$396.00 |
| 86708 |
|
35 |
34 |
$367.95 |
| 86704 |
|
32 |
31 |
$321.60 |
| 82728 |
|
28 |
27 |
$310.70 |
| 86706 |
|
31 |
30 |
$272.89 |
| 86480 |
|
24 |
24 |
$208.22 |
| 86592 |
|
188 |
188 |
$205.20 |
| 82570 |
|
170 |
166 |
$198.41 |
| 83550 |
|
30 |
29 |
$184.14 |
| 82043 |
|
110 |
110 |
$176.82 |
| 83540 |
|
34 |
33 |
$175.46 |
| 87070 |
|
24 |
24 |
$157.52 |
| 99000 |
|
43 |
38 |
$150.78 |
| 82248 |
|
18 |
18 |
$74.29 |
| 85027 |
|
108 |
108 |
$52.61 |
| 86140 |
|
12 |
12 |
$50.38 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
37 |
29 |
$48.95 |
| 0510 |
|
12 |
12 |
$47.06 |
| 85652 |
|
25 |
25 |
$31.38 |
| 84153 |
|
14 |
14 |
$16.35 |
| 81003 |
|
13 |
13 |
$2.26 |
| 3074F |
|
355 |
318 |
$0.00 |
| 1126F |
|
48 |
42 |
$0.00 |
| 3008F |
|
173 |
146 |
$0.00 |
| 2010F |
|
81 |
66 |
$0.00 |
| 80371 |
|
133 |
126 |
$0.00 |
| 80050 |
General health panel |
909 |
908 |
$0.00 |
| 2001F |
|
81 |
66 |
$0.00 |
| 80368 |
|
100 |
95 |
$0.00 |
| 84436 |
|
27 |
26 |
$0.00 |
| 2000F |
|
79 |
64 |
$0.00 |
| 80355 |
|
133 |
126 |
$0.00 |
| 80362 |
|
133 |
127 |
$0.00 |
| 80365 |
|
80 |
75 |
$0.00 |
| 80361 |
|
93 |
88 |
$0.00 |
| 80366 |
|
133 |
126 |
$0.00 |
| 80372 |
|
133 |
126 |
$0.00 |
| 3078F |
|
325 |
297 |
$0.00 |
| 80369 |
|
133 |
126 |
$0.00 |
| 80373 |
|
135 |
128 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
69 |
63 |
$0.00 |
| 80360 |
|
120 |
115 |
$0.00 |
| 92015 |
Determination of refractive state |
16 |
16 |
$0.00 |
| 98940 |
|
81 |
50 |
$0.00 |
| 1160F |
|
21 |
15 |
$0.00 |
| 1159F |
|
21 |
15 |
$0.00 |